Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT01509105

Completed

Prevenar13 Post Market Surveillance

Healthy
NCT02632578

Completed

Influenza Vaccine in HIV Study

Influenza, Human
NCT00161837

Completed

Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004

Influenza
NCT00501137

Completed

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine (BCGov-01)

Cervical Cancer | Genital Warts
NCT01764126

Completed

Pneumococcal Protein Vaccine Safety and Immunogenicity Trial (PPR02)

Adverse Effects
NCT00433745

Completed

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Myelodysplastic Syndrome | Acute Myeloid Leukemia (AML) | Chronic Myeloid Leukemia (CML)
NCT00500266

Completed

Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects

Pneumococcal Infections
NCT00546572

Completed

Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

Pneumococcal Infections
NCT00683410

Completed

Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)

Vaccines, Pneumococcal Conjugate Vaccine
NCT00371878

Completed

Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection

Pneumonia | HIV | Meningitis | Invasive Pneumococcal Disease
NCT00116467

Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Acute Myelogenous Leukemia
NCT03888924

Recruiting

Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)

Multiple Sclerosis
NCT04704830

Active, not recruiting

R21/Matrix-M in African Children Against Clinical Malaria

Malaria
NCT00436007

Completed

Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen

Malaria
NCT02558751

Completed

Pneumonia Vaccine in Aging HIV Positive Individuals

Pneumococcal Infection
NCT00260039

Completed

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Cervical Cancer | HPV | Premalignancy Anogenital Warts
NCT00474487

Completed

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Meningococcal Infections | Meningococcal Meningitis
NCT00093548

Withdrawn

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer

Liver Cancer
NCT05000216

Terminated

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Systemic Lupus Erythematosus (SLE) | Multiple Sclerosis (MS) | Rheumatoid Arthritis (RA) | Juvenile Dermatomyositis (JDM) | Juvenile Idiopathic Arthritis (JIA) | Pemphigus Vulgaris | Systemic Sclerosis (SSc) | Pediatric SLE | Pediatric-Onset Multiple Sclerosis (POMS)
NCT05820594

Recruiting

Using BCG Vaccine to Understand Tuberculosis Infection (Pilot BCG CHIM)

Tuberculosis
NCT05494047

Recruiting

Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile (TetraFluVac)

Influenza | Vaccines
NCT05645900

Completed

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

Influenza
NCT03614533

Completed

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Typhoid
NCT05071313

Completed

A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Influenza, Human Prevention | Respiratory Syncytial Viruses Prevention
NCT01824537

Completed

Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study (TRAP-HPV)

Human Papillomavirus Infection
NCT03179761

Completed

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Hematopoietic Cell Transplantation
NCT05142319

Completed

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] (PRIBIVAC)

COVID-19
NCT05135273

Completed

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali

Malaria,Falciparum
NCT05685953

Completed

A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine (OpenCorona1)

COVID-19 Respiratory Infection | COVID-19 Vaccine Adverse Reaction
NCT03485365

Completed

A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)

Pain, Inflammatory
NCT00003871

Completed

PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer

Prostate Cancer
NCT01812135

Withdrawn

Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants

Infection, Viral, Enterovirus
NCT03294551

Completed

HPV Centralized R/R RCT #2 - New York State

Vaccines
NCT03139565

Completed

High Dose vs. Standard Influenza Vaccine in Adult SOT

Influenza | Immunosuppression
NCT03208101

Completed

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection
NCT03682939

Unknown

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (ProPositive)

HIV Infections | Hiv | Meningitis, Meningococcal
NCT01567865

Completed

Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

Japanese Encephalitis
NCT00714285

Completed

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

Influenza
NCT00363545

Completed

To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

Infections, Rotavirus
NCT02692599

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps
NCT02038907

Completed

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine (NOR-107)

Healthy Volunteers | Norovirus, Prevention
NCT01193335

Completed

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.

Premature Birth | Safety | Immunization | 13-valent Pneumococcal Vaccine
NCT01505647

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Herpes Zoster | Shingles
NCT00197249

Completed

Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity

Hepatitis A
NCT02819180

Completed

Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB (FLU-02-IB)

Influenza
NCT00766285

Withdrawn

High Dose Influenza in Immunosuppressed Subjects

Influenza
NCT00104845

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Melanoma (Skin)
NCT00464945

Completed

Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Pneumococcal Vaccines
NCT00743652

Completed

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Pneumococcal Disease | 13-valent Pneumococcal Vaccine
NCT02479373

Completed

Exercise and Body Composition in Juvenile Idiopathic Arthritis (Joint Fitness)

Arthritis, Juvenile

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations